The American College of Rheumatology’s Research and Education Foundation (REF) has renamed itself “The Rheumatology Research Foundation: Advancing treatment, Finding cures,” as part of an overall branding strategy for the ever-growing fundraising branch of the ACR that better defines its mission and goals
What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?
The Centers for Medicare and Medicaid Services (CMS) Stage 2 Meaningful Use rule will focus on using data collected for more advanced clinical processes
ACR Increases Its Role in Educating Rheumatologists About Treating Geriatric Patients
Sessions on aging and rheumatic disease, arthritis and the older worker, and back pain in the elderly included at the annual meeting of the American College of Rheumatology and Association of Rheumatology Healthcare Professionals (ACR/ARHP)
Rheumatologists Seek Public Vote for Research Grant Award
Brigham and Women’s docs compete for BRIght Futures Prize for personalized medicine research
Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)
EULAR: Identify Arthritis Early, Treat it Effectively
Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology
Career marked by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis
Maintenance of Remission in ANCA-Associated Vasculitis
Relapses are common, but difficult to predict and prevent.
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Why We Are Advocates
Rheumatology advocacy efforts are paying off in 2012.
- « Previous Page
- 1
- …
- 88
- 89
- 90
- 91
- 92
- …
- 123
- Next Page »